Blog Syngene Contact Us    Quick links
About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
Biocon Quarterly Results
  > INVESTORS
  Overview
  Corporate Structure
  Corporate Governance
  Company History
  Annual General Meeting
  Postal Ballot
  Investor FAQs
  Stock Info
  Financial Results
  Subsidiary Financials
  Annual Report
  Disclosure to Stock Exchange
  Nomination form
  Press Releases
  Presentations
  Analyst Coverage
  Investor Contacts
  
  
     
 
Financials

Financial Results

 
 
 
 
  FY 16-17 Q1 H1 9M FY
  Notice Ad Notice Ad Q1 FY 2016-17 Notice Ad Q2 FY 2016-17 Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17
  Press Release Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17
  Fact Sheet Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17
  Transcript of the Call Transcript of Q1 FY17 Press Release Q1 FY 2016-17 Press Release Q1 FY 2016-17
  Newspaper Advertisement Press Release Q1 FY 2016-17 Q4 FY 2016-17 Results
  Results Press Release Q1 FY 2016-17 FY 17 Results
  Investor Presentation - Investor Presentation April 2017

Previous Year 2016-17 Financial Highlights

In Rs. Crore 
  FY 16-17 Q1 H1 9M FY
  Revenue 1033 2026 3117 4079
  EBITDA 304 581 906 1137
  Net Profit 167 311 485 612
  R&D Expenses in P&L 52 117 201 267
  Total R&D Spends 92 205 304 402
  EBITDA Margins 28% 29% 29% 28%
  Net Profit Margins 15% 15% 16% 15%

 

  
     
  FY16-17  FY16-17  FY16-17  FY15-16  FY14-15  FY13-14  FY12-13  FY11-12  FY10-11  FY09-10  FY08-09  FY07-08  FY06-07  FY05-06  FY04-05 

 
Quarterly Results
 FY20-21
 FY19-20
 FY18-19
 FY17-18
 FY16-17
 FY15-16
 FY14-15
 FY13-14
 FY12-13
 FY11-12
 FY10-11
 FY09-10
 FY08-09
 FY07-08
 FY06-07
 FY05-06
 FY04-05
 
 
     
  Biocon

Businesses

 Recommended sites Biocon on  
  Home
About Us
Investor Relations
Media Relations
Careers
Site Map
Contact Us 		Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

 ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved